Role of diet in diseases and disorders : Use of dose response studies to define the lowest level of intake of n-3 PUFA which exert a positive nutritional effect against biomakers of chronic diseases in humans. These biomarkers include the lowering of plasma triaglycerol, reducing cytokine production and the thrombotic tendancy of blood.
Functional foods : Design a range of microencapsulated n-3 PUFA functional
ingredients with high levels of n-3 PUFA which can be used in a wide range of end products and for a wide range of specific consumer groups.
Nutritional adequacy & bioavailability : Optimise the bioavailability/oxidative stability balance by cooperative effort between process technology development and nutritional bioavailability studies. The technologies evaluated shall include antioxidant stabilisation and microencapsulation.
Tasks : The main tasks involved shall include the following : dose reponse study; sourcing & stabilisation of fish oil; development and use of novel analytical techniques; process development; shelf life optimisation studies; n-3 PUFA bioavailability studies; applications development - explore a number of possible end end use products; the project should be completed in 3 years.
The team : This project is led by a successful Irish Dairy Company who have recently launched a n-3 PUFA
Funding SchemeCSC - Cost-sharing contracts
114 86 Stockholm
Fermoy Co Cork
BT52 1SA Coleraine